NIP
ASTH icon

Nicholas Investment Partners’s Astrana Health ASTH Stock Holding History

Nicholas Investment Partners’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-48,131
Closed -$2.79M – 252
2024
Q3 		$2.79M Buy
+48,131
New +$2.36M 0.26% 141

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nicholas Investment Partners's ASTH Position: Q4 2024 in Review

Nicholas Investment Partners sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 48,131 shares — an estimated $2.79M sold.

Nicholas Investment Partners first reported a position in ASTH in Q3 2024 and held it in 1 quarter. The position peaked at $2.79M in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Nicholas Investment Partners reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Nicholas Investment Partners sold 48,131 Astrana Health shares in Q4 2024, an estimated $2.79M.
  • Nicholas Investment Partners first reported a position in Astrana Health in Q3 2024 and held it in 1 quarter.
  • Nicholas Investment Partners's Astrana Health position peaked at $2.79M in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Nicholas Investment Partners's 13F filing for Q4 2024, filed 14 Feb 2025.